Hybrid Metabolic Activity-Related Prognostic Model and Its Effect on Tumor in Renal Cell Carcinoma

Table 1

The clinical characteristics, pathological characteristics, and follow-up outcomes of the patients included in the training set. AJCC: American Joint Committee on Cancer.

Characteristics	Group	Patients (n, %)
Age	≥65	193 (36.76)
	<65	332 (63.24)
Gender	Male	343 (65.33)
	Female	182 (34.67)
Grade	1-2	239 (45.52)
	3-4	278 (52.95)
	Unknown	8 (1.52)
AJCC stage	I-II	317 (60.38)
	III-IV	205 (39.05)
	Unknown	3 (0.57)
T satge	T1-T2	335 (63.81)
	T3-T4	190 (36.19)
N stage	N0	237 (45.14)
	N1	16 (3.05)
	Unknown	272 (51.81)
Metastasis	M0	417 (79.43)
	M1	78 (14.86)
	Unknown	30 (5.71)
Survival status	Alive	361 (68.76)
	Dead	164 (31.24)